ERBB2 and breast cancer: Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer and, in the absence of expression of hormone and HER2 growth factor receptors, it is treated with chemotherapy either before surgery (neoadjuvant chemotherapy—NAC), or after (adjuvant chemotherapy).